MUC12: A Drug Target / Disease Biomarker (G10071)
MUC12: A Drug Target / Disease Biomarker
MUC12 is a protein that is expressed in various tissues throughout the body, including the lungs, heart, kidneys, and brain. It is a member of the middleucan family of proteins, which are characterized by the presence of a unique transmembrane domain and a cytoplasmic tail.
MUC12 has been identified as a potential drug target due to its involvement in various cellular processes that are important for maintaining tissue health and function. One of the key functions of MUC12 is its role in cell-cell adhesion, as it is known to be involved in the formation of tight junctions between epithelial cells. This is important for maintaining the integrity of the barrier between tissues and ensuring proper exchange of nutrients and waste products.
In addition to its role in cell-cell adhesion, MUC12 is also involved in several other cellular processes that are important for maintaining tissue health and function. For example, it has been shown to be involved in the regulation of inflammation and fibrosis, as well as in the development and progression of various diseases, including cancer.
One of the reasons why MUC12 has been identified as a potential drug target is its unique expression pattern. MUC12 is expressed in a wide range of tissues throughout the body, but its levels are highly variable depending on the specific tissue type and the context in which it is expressed. This variation in expression patterns makes it an attractive target for researchers to study and potentially identify new drug candidates.
Another reason why MUC12 has been identified as a potential drug target is its role in the development and progression of various diseases. For example, MUC12 has been shown to be involved in the development of cancer, and it has been identified as a potential biomarker for this disease. Additionally, MUC12 has been shown to be involved in the regulation of several diseases, including heart disease, diabetes, and neurodegenerative diseases.
Despite the potential benefits of MUC12 as a drug target, it is important to note that its high expression levels in various tissues make it a difficult target to study and develop drugs for. Additionally, the study of MUC12 as a drug target is still in its early stages, and much more research is needed to fully understand its role in various biological processes and its potential as a drug target.
In conclusion, MUC12 is a protein that has been identified as a potential drug target due to its involvement in various cellular processes that are important for maintaining tissue health and function. Its unique expression pattern and its role in the development and progression of various diseases make it an attractive target for researchers to study and potentially identify new drug candidates. Further research is needed to fully understand its role in these processes and its potential as a drug target.
Protein Name: Mucin 12, Cell Surface Associated
Functions: Involved in epithelial cell protection, adhesion modulation, and signaling. May be involved in epithelial cell growth regulation. Stimulated by both cytokine TNF-alpha and TGF-beta in intestinal epithelium
The "MUC12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MUC12 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MUC13 | MUC15 | MUC16 | MUC17 | MUC19 | MUC2 | MUC20 | MUC20P1 | MUC21 | MUC22 | MUC3A | MUC3B | MUC4 | MUC5AC | MUC5B | MUC6 | MUC7 | MUC8 | Mucin | MUCL1 | MUCL3 | MUL1 | Multisubunit histone acetyltransferase complex | MUPP | MUS81 | Muscarinic Acetylcholine Receptor (mAChR) | MUSK | MUSTN1 | MUTYH | MVB12A | MVB12B | MVD | MVK | MVP | MX1 | MX2 | MXD1 | MXD3 | MXD4 | MXI1 | MXRA5 | MXRA5Y | MXRA7 | MXRA8 | MYADM | MYADML | MYADML2 | MYB | MYBBP1A | MYBL1 | MYBL2 | MYBPC1 | MYBPC2 | MYBPC3 | MYBPH | MYBPHL | MYC | MYCBP | MYCBP2 | MYCBP2-AS1 | MYCBPAP | MYCL | MYCL-AS1 | MYCLP1 | MYCN | MYCNOS | MYCNUT | MYCT1 | MYD88 | MYDGF | MYEF2 | Myelin Protein | MYEOV | MYF5 | MYF6 | MYG1 | MYH1 | MYH10 | MYH11 | MYH13 | MYH14 | MYH15 | MYH16 | MYH2 | MYH3 | MYH4 | MYH6 | MYH7 | MYH7B | MYH8 | MYH9 | MYHAS | MYL1 | MYL10 | MYL11 | MYL12A | MYL12B | MYL12BP3 | MYL2 | MYL3
